136 related articles for article (PubMed ID: 33187581)
1. Co-Polymer Functionalised Gold Nanoparticles Show Efficient Mitochondrial Targeted Drug Delivery in Cervical Carcinoma Cells.
Oladimeji O; Akinyelu J; Singh M
J Biomed Nanotechnol; 2020 Jun; 16(6):853-866. PubMed ID: 33187581
[TBL] [Abstract][Full Text] [Related]
2. Modified Gold Nanoparticles for Efficient Delivery of Betulinic Acid to Cancer Cell Mitochondria.
Oladimeji O; Akinyelu J; Daniels A; Singh M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064888
[TBL] [Abstract][Full Text] [Related]
3. Effects of bisphosphonate ligands and PEGylation on targeted delivery of gold nanoparticles for contrast-enhanced radiographic detection of breast microcalcifications.
Cole LE; McGinnity TL; Irimata LE; Vargo-Gogola T; Roeder RK
Acta Biomater; 2018 Dec; 82():122-132. PubMed ID: 30316022
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Biological Activity of Folic Acid-Modified Paclitaxel-Loaded Gold Nanoparticles.
Ren B; Cai ZC; Zhao XJ; Li LS; Zhao MX
Int J Nanomedicine; 2021; 16():7023-7033. PubMed ID: 34703225
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of mitochondria-targeted polymeric nanoparticles.
Marrache S; Pathak RK; Dhar S
Methods Mol Biol; 2015; 1265():103-12. PubMed ID: 25634270
[TBL] [Abstract][Full Text] [Related]
7. Multi-functional core-shell Fe
S R; M P
Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046
[TBL] [Abstract][Full Text] [Related]
8. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
9. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
Nie L; Sun S; Sun M; Zhou Q; Zhang Z; Zheng L; Wang L
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658190
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
Rahme K; Guo J; Holmes JD; O'Driscoll CM
Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
[TBL] [Abstract][Full Text] [Related]
13. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.
Liu X; Huang N; Wang H; Li H; Jin Q; Ji J
Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246
[TBL] [Abstract][Full Text] [Related]
14. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.
Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM
J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation.
Rahimi-Moghaddam F; Azarpira N; Sattarahmady N
Lasers Med Sci; 2018 Nov; 33(8):1769-1779. PubMed ID: 29790012
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate-capped gold nanoparticles enhanced the tumor suppressors let-7a and miR-34a in hepatocellular carcinoma cells.
Mostafa SM; Gamal-Eldeen AM; Maksoud NAE; Fahmi AA
An Acad Bras Cienc; 2020; 92(4):e20200574. PubMed ID: 33206791
[TBL] [Abstract][Full Text] [Related]
17. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
18. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
19. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
